Since vascular inflammation plays an important role in development of atherosclerosis and specifically high-risk lesions in human and DM/HC porcine coronary arteries, it was hypothesized that selective inhibition of lipoprotein associated phospholipase A2 (Lp-PLA2) could reduce lesion development in this model [8]. This evidence concerns the gene PLA2G7 and diabetes mellitus.